Vaishali Pharma Board to Consider Preferential Issue and Capital Increase
Vaishali Pharma Ltd 路 Intimation 路 03 Nov 2026, 2:58 am
Vaishali Pharma Board to Consider Preferential Issue and Capital Increase Vaishali Pharma scheduled a Board meeting on 5th Nov'26 to evaluate raising funds via a preferential issue of equity shares. The Board will also consider increasing authorized share capital from INR 27.00 Cr (13.50 Cr shares of INR 2 each) to INR 29.00 Cr (14.50 Cr shares of INR 2 each), appointing Rohil Sanjay Desai and Ketur Kishor Shah as Additional Independent Non-Executive Directors, and initiating a postal ballot to seek shareholder approval for these proposals.
Original exchange filing (PDF)
More announcements from Vaishali Pharma Ltd
- Vaishali Pharma Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 路 15 Nov 2026
- Vaishali Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 15 Nov 2026
- Vaishali Pharma Limited has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended September 2026 and Other business. 路 14 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 and other business matters 路 14 Nov 2026
- Vaishali Pharma Limited has informed the Exchange regarding Appointment of Mr. Rohil Sanjay Desai and Mr. Ketur Kishor Shah as Non- Executive Independent Director of the company w.e.f. November 05, 2026. 路 06 Nov 2026
- Vaishali Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on November 05, 2026. 路 06 Nov 2026
- Vaishali Pharma Limited has informed the Exchange about Board Meeting to be held on 05-Nov-2026 to consider and approve Other business/Increase in authorised capital/Fund raising. 路 03 Nov 2026
- Vaishali Pharma Limited has informed the Exchange about General Updates 路 17 Oct 2026
